Close Menu

NEW YORK (360Dx) – Roche and Foundation Medicine said this week that Roche's wholly owned subsidiary called 062018 Merger Subsidiary has purchased approximately 12.5 million shares of Foundation Medicine's common stock at a price of $137 per share as part Roche's tender offer for the company, which expired at the end of July 30.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.